Ionis Pharmaceuticals, Inc. Investments, Fair Value Disclosure
Ionis Pharmaceuticals, Inc. (IONS) had Investments, Fair Value Disclosure of $714.82 million as of 2015-06-30, per its 10-Q filed 2015-08-05.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures
us-gaap:InvestmentsFairValueDisclosure · last filed 2015-08-05
- 2015-06-30: Investments, Fair Value Disclosure $714.82M.
- 2015-03-31: Investments, Fair Value Disclosure $649.20M.
- 2014-12-31: Investments, Fair Value Disclosure $687.79M.
- 2014-09-30: Investments, Fair Value Disclosure $582.08M.
| Period end | Investments, Fair Value Disclosure | Investments, Fair Value Disclosure as first filed |
|---|---|---|
| 2015-06-30 | $714.82M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $649.20M 10-Q · filed 2015-05-05 | |
| 2014-12-31 | $687.79M 10-Q · filed 2015-08-05 | |
| 2014-09-30 | $582.08M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $575.03M 10-Q · filed 2014-08-04 | |
| 2014-03-31 | $545.56M 10-Q · filed 2014-05-06 | |
| 2013-12-31 | $563.91M 10-K · filed 2015-03-02 | |
| 2013-03-31 | $312.37M 10-Q · filed 2013-05-07 | |
| 2012-12-31 | $293.08M 10-K · filed 2014-03-03 | $289.08M 10-K · filed 2013-02-28 |
| 2012-09-30 | $262.82M 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $253.61M 10-Q · filed 2012-08-06 | |
| 2012-03-31 | $279.44M 10-Q · filed 2012-05-09 | |
| 2011-12-31 | $280.09M 10-K · filed 2013-02-28 | |
| 2011-09-30 | $311.29M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $312.38M 10-Q · filed 2011-08-08 | |
| 2010-12-31 | $404.94M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |